Opus Genetics IRD
NASDAQ IRD
$4.58 +0.07 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Sales of Property, Plant and Equipment (2019)

Updated

Opus Genetics (IRD) posted Sales of Property, Plant and Equipment of $5,500 for FY2019.

Analysis

Opus Genetics (IRD) Sales of Property, Plant and Equipment (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Opus Genetics 378.53 Mn 153.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 5,500.00
API Access

Opus Genetics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=IRD&period=max&api_key=YOUR_API_KEY